The United Laboratories International Holdings (3933.HK) Earnings Analysis

The United Laboratories International Holdings (3933.HK) next reports earnings on 2026-08-27, consensus EPS 0.4965 HKD. Last quarter (2026-03-24) it beat with EPS 0.1224 HKD vs 0.06677 HKD est (+83.3%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E 6.92.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 3933.HK next report earnings?

Next earnings date2026-08-27
Consensus EPS estimate0.4965 HKD
Revenue estimate6.87B

3933.HK earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-240.1224 HKD0.06677 HKD+83.3%Beat
2025-09-011.14 HKD1.46 HKD-21.9%Miss
2024-12-310.684 HKD0.83 HKD-17.6%Miss

Beat rate: 1/3 (33%) over reported quarters with consensus data.

3933.HK valuation and analyst view

Trailing P/E6.92
Trailing EPS1.068 HKD
Price / book0.88
Dividend yield3.28%
Market cap18.17B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is The United Laboratories International Holdings (3933.HK)'s next earnings date?

The United Laboratories International Holdings is next scheduled to report on 2026-08-27, with a consensus EPS estimate of 0.4965 HKD and revenue estimate of 6.87B.

Did 3933.HK beat earnings last quarter?

In its 2026-03-24 report, 3933.HK posted EPS of 0.1224 HKD versus a 0.06677 HKD estimate — a beat of 83.3%.

What is 3933.HK's earnings track record?

Over the last 3 reported quarters with consensus data, 3933.HK beat estimates 1 times (33%).

What is 3933.HK's current P/E ratio and EPS?

3933.HK trades at a trailing P/E of 6.92 on trailing EPS of 1.0678832274522079 HKD.

What do analysts rate 3933.HK?

3933.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.